95 related articles for article (PubMed ID: 23417498)
1. VEGF-B expression in colorectal carcinomas and its relevance for tumor progression.
Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
Histol Histopathol; 2013 May; 28(5):647-53. PubMed ID: 23417498
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
[TBL] [Abstract][Full Text] [Related]
4. Endothelial VEGFR-3 expression in colorectal carcinomas is associated with hematogenous metastasis.
Jayasinghe C; Simiantonaki N; Michel-Schmidt R; Kirkpatrick CJ
Oncol Rep; 2009 Nov; 22(5):1093-100. PubMed ID: 19787226
[TBL] [Abstract][Full Text] [Related]
5. Cell type- and tumor zone-specific expression of pVEGFR-1 and its ligands influence colon cancer metastasis.
Jayasinghe C; Simiantonaki N; Kirkpatrick CJ
BMC Cancer; 2015 Mar; 15():104. PubMed ID: 25880726
[TBL] [Abstract][Full Text] [Related]
6. Epithelial expression of VEGF receptors in colorectal carcinomas and their relationship to metastatic status.
Simiantonaki N; Taxeidis M; Jayasinghe C; Kirkpatrick CJ
Anticancer Res; 2007; 27(5A):3245-50. PubMed ID: 17970067
[TBL] [Abstract][Full Text] [Related]
7. Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Abajo A; Bitarte N; Zarate R; Boni V; Lopez I; Gonzalez-Huarriz M; Rodriguez J; Bandres E; Garcia-Foncillas J
World J Gastroenterol; 2012 Feb; 18(7):637-45. PubMed ID: 22363134
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
Martins SF; Garcia EA; Luz MA; Pardal F; Rodrigues M; Filho AL
Cancer Genomics Proteomics; 2013; 10(2):55-67. PubMed ID: 23603341
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Cell Proliferation and Vascular Endothelial Growth Factor Expression in Primary Colorectal Cancer and Corresponding Liver Metastases.
Raluca BA; Cimpean AM; Cioca A; Cretu O; Mederle O; Ciolofan A; Gaje P; Raica M
Asian Pac J Cancer Prev; 2015; 16(11):4549-53. PubMed ID: 26107202
[TBL] [Abstract][Full Text] [Related]
12. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
Witte D; Thomas A; Ali N; Carlson N; Younes M
Anticancer Res; 2002; 22(3):1463-6. PubMed ID: 12168824
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor receptor expression as a prognostic marker for survival in colorectal cancer.
Okita NT; Yamada Y; Takahari D; Hirashima Y; Matsubara J; Kato K; Hamaguchi T; Shirao K; Shimada Y; Taniguchi H; Shimoda T
Jpn J Clin Oncol; 2009 Sep; 39(9):595-600. PubMed ID: 19535387
[TBL] [Abstract][Full Text] [Related]
14. [Expression and pathobiological implication of hypoxia-inducible factor-1alpha in human colorectal carcinoma].
Fan LF; Diao LM; Jiang CQ; Tang ZJ; Xia D; Liu MQ; Liu ZS; Ai ZL
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):242-6. PubMed ID: 15256117
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma.
Ochiumi T; Tanaka S; Oka S; Hiyama T; Ito M; Kitadai Y; Haruma K; Chayama K
Int J Oncol; 2004 Mar; 24(3):539-47. PubMed ID: 14767538
[TBL] [Abstract][Full Text] [Related]
16. [Liver metastasis in colorectal cancer and tumor angiogenesis].
Xie Z; Huang X; Li J; Zhou L
Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):336-7, 21. PubMed ID: 11829853
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
18. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
[TBL] [Abstract][Full Text] [Related]
19. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
Hong KD; Lee Y; Kim BH; Lee SI; Moon HY
Am Surg; 2013 Feb; 79(2):198-204. PubMed ID: 23336661
[TBL] [Abstract][Full Text] [Related]
20. Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma.
Kuwai T; Kitadai Y; Tanaka S; Onogawa S; Matsutani N; Kaio E; Ito M; Chayama K
Int J Cancer; 2003 Jun; 105(2):176-81. PubMed ID: 12673675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
